Pain Management

The researchers said their results have potential implications for pain management and wellness in older adults, and they suggest that pain catastrophizing could be an important therapeutic target for interventions and pain treatment.

The finding about mindfulness-based stress reduction (MBSR) was a secondary outcome of the double-blinded, randomized, placebo-controlled clinical trial. The primary outcome—a reduction in the frequency of migraines—was not reached.

Scientists in Japan describe how a population of spinal cord astrocytes appear to have a role in producing pain hypersensitivity.

Previous studies have suggested that migraine is linked with higher visual neuronal excitability, which can be inhibited through noninvasive brain stimulation.

The study compared females and males who suffer from migraines and other painful conditions who took part in a national health survey in Spain.

Menstrual-related migraines that occur after estradiol drops often carry with it disabling pain and heightened pain sensitivity, but why this is so is unknown.

A multidisciplinary spine intervention can reduce chronic back pain–related health care utilization and costs, according to a study published in Spine.

Using virtual reality led to significant reductions in pain for participants in 12 of the 18 studies.

A vegan diet is one that physicians may want to consider for their patients with painful diabetic neuropathy, according to a recent review.

Migraine can affect children’s quality of life, and a recent study examined the use of melatonin to treat pediatric acute migraine.

The study compared patients given-low-dose ketamine with those given morphine for acute pain relief.

Recent research explored opportunities to improve care for those with acute migraine.

Two abstracts presented at the Migraine Trust Virtual Symposium investigated lasmiditan’s safety in elderly and pediatric migraine patients.

Abstracts presented at this year’s Migraine Trust International Symposium (MTIS) show how researchers analyzed the efficacy, tolerability, and safety profile of Reyvow (lasmiditan), a prescription drug used to treat migraine attacks.

Understanding and targeting all factors involved in chronic pain can improve the success of treatments.

The characteristics and degree of psychosocial morbidity in patients with orofacial pain is significantly related to the types of presenting orofacial symptoms.

A study looking at older adults with chronic pain found no significant difference in cognitive performance when comparing them with matched patients who did not use medical cannabis.

Patients with migraine who took lasmiditan (Reyvow) for acute pain during attacks had greater odds of reaching pain freedom, according to results of a phase 3 trial.

The survey was released to mark Pain Awareness Month.

Pain, fatigue, and depression are 1 cluster of symptoms afflicting 1 in 13 survivors of prostate cancer, according to a recent study.

A formulation of dihydroergotamine (DHE) in a nasal powder form was no different than placebo for relief from pain and annoying symptoms at 2 hours post dose.

In clinical practice, lasmiditan may be given together with propranolol; investigators wanted to test the cardiovascular effects of coadministration.

A review warns against delaying or ignoring the concerns of individuals with chronic pain during the coronavirus disease 2019 (COVID-19) pandemic.

A recent case report describes a woman with COVID-19 who has had a continuous headache and has not regained her sense of smell since having the disease months ago.

The report explored the use of intravenous lidocaine in a hospital that expanded its use beyond postoperative gastrointestinal surgery.